215 related articles for article (PubMed ID: 8999421)
1. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
3. [Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma].
Hervás Benito I; Rivas Sánchez A; Bello Arques P; Cañete A; Fernández JM; Saura Quiles A; González Cabezas P; Ruiz Rodríguez JC; Castell V; Pérez Pastor JL; Monfort JA; Mateo Navarro A
Rev Esp Med Nucl; 2001 Aug; 20(5):369-76. PubMed ID: 11470071
[TBL] [Abstract][Full Text] [Related]
4. [Indications for MIBG scintigraphy in the diagnosis of neuroblastoma].
Hausegger KA; Fueger GF; Ebner F; Urban C
Nuklearmedizin; 1989 Feb; 28(1):34-40. PubMed ID: 2710644
[TBL] [Abstract][Full Text] [Related]
5. [123I-MIBG scintigraphy in patients with neuroblastoma].
Koizumi M; Sawada H; Goto M; Iijima A; Watari T; Kurosawa H; Kurumada H; Sugita K; Furukawa T
Kaku Igaku; 1994 May; 31(5):507-11. PubMed ID: 8028223
[TBL] [Abstract][Full Text] [Related]
6. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
7. [Results of scintigraphy with m-[123I]iodobenzylguanidine in neuroblastoma in children].
Ythier H; Marchandise X; Deveaux M; Venel H; Verney F; Mazingue F; Millot F
Int J Rad Appl Instrum B; 1987; 14(2):107-12. PubMed ID: 3597111
[TBL] [Abstract][Full Text] [Related]
8. [Recurrence of a stage IV neuroblastoma].
Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
Nuklearmedizin; 1997 Jan; 36(1):32-5. PubMed ID: 9082339
[TBL] [Abstract][Full Text] [Related]
9. [Bone marrow metastases of neuroblastoma: MRT in comparison with bone marrow cytology and mIBG scintigraphy].
Benz-Bohm G; Gross-Fengels W; Widemann B; Linden A
Rofo; 1990 May; 152(5):523-7. PubMed ID: 2160683
[TBL] [Abstract][Full Text] [Related]
10. [Scintigraphic diagnosis of neuroblastoma using meta-iodobenzylguanidine].
Kimmig B; Brandeis WE; Eisenhut M; Ludwig R; Adolph J
Klin Padiatr; 1986; 198(3):224-9. PubMed ID: 3723986
[TBL] [Abstract][Full Text] [Related]
11. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
Sautter-Bihl ML; Bihl H; Heinze HG
Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
[TBL] [Abstract][Full Text] [Related]
12. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
Shulkin BL; Shapiro B; Hutchinson RJ
J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
[TBL] [Abstract][Full Text] [Related]
13. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract][Full Text] [Related]
14. [Iodine-123-MIBG scintigraphy in neuroblastoma; relationship between the intensity of uptake and tumor characteristics].
Okuyama C; Ushijima Y; Watanabe K; Sugihara H; Nishimura T
Kaku Igaku; 1999 Oct; 36(8):827-34. PubMed ID: 10586543
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
[TBL] [Abstract][Full Text] [Related]
18. Diffuse bone marrow uptake [123I]MIBG in neuroblastoma: an "MIBG super scan" case report.
Giammarile F; Olier AL; Lumbroso J
Q J Nucl Med; 1995 Jun; 39(2):119-21. PubMed ID: 8574805
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H
Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911
[TBL] [Abstract][Full Text] [Related]
20. The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma.
Abrahamsen J; Lyck B; Helgestad J; Frederiksen PB
Acta Oncol; 1995; 34(4):505-10. PubMed ID: 7605659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
